
亚太地区人工颈椎间盘市场预测至 2028 年 – COVID-19 影响和区域分析 – 按材料(生物聚合物材料和金属材料)和最终用户(医院、门诊手术中心等)
No. of Pages: 111 | Report Code: BMIRE00025515 | Category: Life Sciences
No. of Pages: 111 | Report Code: BMIRE00025515 | Category: Life Sciences
随着制造成本的增加,医疗设备制造商很难产生足够的收入来取悦投资者。发展中经济体的新兴市场对于为主要参与者提供更好、更有利可图的增长机会以扩大其业务和地理范围至关重要。在先进医疗技术的帮助下,骨科疾病的治疗变得更加简单。人工颈椎间盘置换手术等微创手术减少了大剂量药物的消耗。亚太地区对这些骨科手术的采用可能会增加。
亚太地区对医疗保健行业的投资更多。该地区各国政府正在通过各种举措积极提高人们对微创骨科手术的认识。印度、中国等经济体的医疗保健支出不断增长,创造了许多机会,从而提供了更好的服务。这些国家的成年人口和老年人口正在增加。因此,骨科疾病的发病率可能会增加。此外,印度和中国等国家的医疗保健行业初创公司数量有所增加。
在此外,技术先进的基础设施的可用性可能会促进当地企业制造先进骨科产品。因此,未来几年发展中国家市场很可能呈现出较高的增长潜力。
p>
亚太地区人工颈椎间盘市场细分
亚太地区人工颈椎间盘市场根据材料、最终用户和国家/地区进行分析。根据材料,市场分为生物聚合物和金属。 2022年,生物高分子材料领域将占据更大的市场份额。根据最终用户,市场分为医院、门诊手术中心等。 2022年,医院细分市场占据最大市场份额。
按国家划分,亚太市场分为日本、中国、印度、澳大利亚、韩国和亚太其他地区。到2022年底,中国将占据最大的市场份额。
B.布劳恩梅尔苏根股份公司; Globus 医疗有限公司;美敦力; NuVasive 公司; Orthofix 医疗公司;和 Zimmer Biomet Holdings, Inc. 是亚太人工颈椎间盘市场的领先公司。
Strategic insights for Asia Pacific Artificial Cervical Intervertebral Disc involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 369.24 Million |
Market Size by 2028 | US$ 1,023.15 Million |
Global CAGR (2021 - 2028) | 18.5% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 材料
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Artificial Cervical Intervertebral Disc refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
B. Braun Melsugen AG.
Globus Medical, Inc.
Medtronic
NuVasive, Inc.
Orthofix Medical, Inc.
Zimmer Biomet Holdings, Inc.
The Asia Pacific Artificial Cervical Intervertebral Disc Market is valued at US$ 369.24 Million in 2022, it is projected to reach US$ 1,023.15 Million by 2028.
As per our report Asia Pacific Artificial Cervical Intervertebral Disc Market, the market size is valued at US$ 369.24 Million in 2022, projecting it to reach US$ 1,023.15 Million by 2028. This translates to a CAGR of approximately 18.5% during the forecast period.
The Asia Pacific Artificial Cervical Intervertebral Disc Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Artificial Cervical Intervertebral Disc Market report:
The Asia Pacific Artificial Cervical Intervertebral Disc Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Artificial Cervical Intervertebral Disc Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Artificial Cervical Intervertebral Disc Market value chain can benefit from the information contained in a comprehensive market report.